Concepedia

Shunsuke Ebara

SE

Statistics

Publications

8

Citations

516

H-Index

8

Active since

1995

Affiliations

Takeda (Japan)(Current)

Takeda (United States)

Shunsuke Ebara is an author at Takeda (Japan) specializing in oncology, pharmacology, and life sciences.

ORCID

Publications per year

1995–2020

8

Publications

8

Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response

Akito Nakamura, Tadahiro Nambu, Shunsuke Ebara et al. · Proceedings of the National Academy of Sciences · 2018 · 170 citations · Full text

, , +16

Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions

Saomi Murai, Ayumi Ando, Shunsuke Ebara et al. · Oncogenesis · 2017 · 81 citations · Full text

, , +17

Structure of the human aggrecan gene: exon-intron organization and association with the protein domains

Wilmot B. Valhmu, Glyn D. Palmer, Philip Rivers et al. · Biochemical Journal · 1995 · 72 citations

, , +17

Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor

Kenichi Iwai, Tadahiro Nambu, Ryo Dairiki et al. · Science Advances · 2019 · 70 citations · Full text

, , +6

CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells

Akito Nakamura, Daisuke Nakata, Yuichi Kakoi et al. · Oncotarget · 2018 · 49 citations · Full text

, , +17

1–5 of 8